Advanced search
Show most relevant results first | Most recent results are first | Show use by person

Search only Stephen DonnellySearch all speeches

Results 37,021-37,040 of 49,836 for speaker:Stephen Donnelly

Written Answers — Department of Health: National Treatment Purchase Fund (2 Dec 2020)

Stephen Donnelly: The National Treatment Purchase Fund (NTPF) has advised my Department that they are unable to provide average wait times by county for patients referred under the National Treatment Purchase Scheme. It is important to note that the NTPF works with public hospitals, as opposed to with patients directly, to offer and provide the funding for treatment to clinically suitable long waiting...

Written Answers — Department of Health: Cross-Border Health Initiatives (2 Dec 2020)

Stephen Donnelly: I propose to take Questions Nos. 172 and 173 together. The UK’s withdrawal from the EU has implications for healthcare arrangements that currently operate under the EU legislative framework, including those arrangements covered by the Cross Border Directive (CBD). With effect from 1 January 2021, the provisions of the CBD will no longer apply to the UK. My officials are giving...

Written Answers — Department of Health: Rare Diseases (2 Dec 2020)

Stephen Donnelly: Following a request from the HSE Drugs Group, the HSE Rare Diseases Medicinal Products Technology Review Committee convened on 24 September to engage with patients and clinicians in the assessment of two drugs. These are: 1. Burosumab (Crysvita®) for the treatment of X-linked hypophosphataemia with radiographic evidence of bone disease in children 1 year of age and older and adolescents...

Written Answers — Department of Health: Medical Aids and Appliances (2 Dec 2020)

Stephen Donnelly: Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for the administration of the community drug schemes; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

Written Answers — Department of Health: Treatment Benefit Scheme (2 Dec 2020)

Stephen Donnelly: As this is a service matter, I have asked the Health Service Executive to respond to the Deputy directly, as soon as possible.

Select Committee on Health: Estimates for Public Services 2020
Vote 38 - Department of Health (Supplementary)
(2 Dec 2020)

Stephen Donnelly: I thank the select committee for the opportunity to bring this Supplementary Estimate for Vote 38 before it today. I apologise to colleagues for not being available earlier today, as the committee had requested. I was attending a meeting of EU health Ministers, an annual meeting. It was quite long, but it included matters such as a briefing on Covie-19 vaccines so, regrettably, I could not...

Select Committee on Health: Estimates for Public Services 2020
Vote 38 - Department of Health (Supplementary)
(2 Dec 2020)

Stephen Donnelly: Yes, my understanding is that it does. I do not want to eat into the Deputy's time but I could give him the number of millions of doses for each of the five or six vaccines we have.

Select Committee on Health: Estimates for Public Services 2020
Vote 38 - Department of Health (Supplementary)
(2 Dec 2020)

Stephen Donnelly: AstraZeneca’s vaccine is the first one, of which we have 3.3 million doses. We have 2.2 million doses from Janssen, 3.3 million from Sanofi and 2.3 million doses from Pfizer. From Moderna we have 875,000 doses. The sixth vaccine is from CureVac. For the first five companies, we are signed up to the advance purchase agreement and those are the initial doses Ireland will get from...

Select Committee on Health: Estimates for Public Services 2020
Vote 38 - Department of Health (Supplementary)
(2 Dec 2020)

Stephen Donnelly: My understanding is that we are locked in. The mechanism in which the EU is engaged is the advance purchase agreement, which essentially helps with the incentive for the companies.

Select Committee on Health: Estimates for Public Services 2020
Vote 38 - Department of Health (Supplementary)
(2 Dec 2020)

Stephen Donnelly: They are factored in. The Deputy will remember from the budget debate that there is a pot of several hundred million euro as a provision against Covid measures and such things would be pulled from there. The distribution should be, relatively, cheaper than the vaccines themselves. The task force is currently working with the various State agencies on exactly how it would work. The...

Select Committee on Health: Estimates for Public Services 2020
Vote 38 - Department of Health (Supplementary)
(2 Dec 2020)

Stephen Donnelly: Yes it is. I was talking to the public health experts about this today in the context of the statement from the UK yesterday. It is not necessarily the case that whichever vaccine comes on market first will simply be the one that everybody gets. My understanding is that different vaccines may be more suitable for different people or age groups. When we get the validation data from the...

Select Committee on Health: Estimates for Public Services 2020
Vote 38 - Department of Health (Supplementary)
(2 Dec 2020)

Stephen Donnelly: No Government decision has been made on that but my unambiguous view is that the State should cover all costs, just as does with the flu vaccine. We cannot have a situation where there is any question of access being a problem because of affordability.

Select Committee on Health: Estimates for Public Services 2020
Vote 38 - Department of Health (Supplementary)
(2 Dec 2020)

Stephen Donnelly: That is actually decided by NPHET.

Select Committee on Health: Estimates for Public Services 2020
Vote 38 - Department of Health (Supplementary)
(2 Dec 2020)

Stephen Donnelly: That is a good question but I do not want to pre-empt the task force. Professor Brian MacCraith's group will report to the Government on 11 December, which is not that far off. This is exactly the kind of matter on which it will be coming to the Government with details and proposals.

Select Committee on Health: Estimates for Public Services 2020
Vote 38 - Department of Health (Supplementary)
(2 Dec 2020)

Stephen Donnelly: It is. To reiterate, while the EMA is moving faster than normal in making its decisions on the Covid vaccines, it is applying exactly the same quality control. The only reason it is able to move faster is because it has set up special teams, for obvious reasons, because this is so important.

Select Committee on Health: Estimates for Public Services 2020
Vote 38 - Department of Health (Supplementary)
(2 Dec 2020)

Stephen Donnelly: I share the Deputy's concern about this issue. The situation is probably understated in the figures because referrals have also dropped during Covid. The numbers relating to unmet or undiagnosed demand are probably higher in reality. What we are doing at the moment with the HSE is going through exactly that. We have supplied a very large amount of money for the permanent capacity in the...

Select Committee on Health: Estimates for Public Services 2020
Vote 38 - Department of Health (Supplementary)
(2 Dec 2020)

Stephen Donnelly: Sorry-----

Select Committee on Health: Estimates for Public Services 2020
Vote 38 - Department of Health (Supplementary)
(2 Dec 2020)

Stephen Donnelly: That is exactly what we are working through with the HSE at the moment.

Select Committee on Health: Estimates for Public Services 2020
Vote 38 - Department of Health (Supplementary)
(2 Dec 2020)

Stephen Donnelly: No, but by the end of 2020 in the next few weeks we will have targets for the national service plan for next year.

Select Committee on Health: Estimates for Public Services 2020
Vote 38 - Department of Health (Supplementary)
(2 Dec 2020)

Stephen Donnelly: Yes.

   Advanced search
Show most relevant results first | Most recent results are first | Show use by person

Search only Stephen DonnellySearch all speeches